1. Home
  2. FSUN vs COLL Comparison

FSUN vs COLL Comparison

Compare FSUN & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSUN
  • COLL
  • Stock Information
  • Founded
  • FSUN 1892
  • COLL 2002
  • Country
  • FSUN United States
  • COLL United States
  • Employees
  • FSUN N/A
  • COLL N/A
  • Industry
  • FSUN Major Banks
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSUN Finance
  • COLL Health Care
  • Exchange
  • FSUN Nasdaq
  • COLL Nasdaq
  • Market Cap
  • FSUN 997.8M
  • COLL 910.2M
  • IPO Year
  • FSUN N/A
  • COLL 2015
  • Fundamental
  • Price
  • FSUN $33.97
  • COLL $27.01
  • Analyst Decision
  • FSUN Buy
  • COLL Strong Buy
  • Analyst Count
  • FSUN 3
  • COLL 5
  • Target Price
  • FSUN $49.00
  • COLL $43.60
  • AVG Volume (30 Days)
  • FSUN 163.5K
  • COLL 500.0K
  • Earning Date
  • FSUN 04-28-2025
  • COLL 05-08-2025
  • Dividend Yield
  • FSUN N/A
  • COLL N/A
  • EPS Growth
  • FSUN N/A
  • COLL 43.56
  • EPS
  • FSUN 2.69
  • COLL 1.86
  • Revenue
  • FSUN $359,152,000.00
  • COLL $631,449,000.00
  • Revenue This Year
  • FSUN $19.07
  • COLL $19.96
  • Revenue Next Year
  • FSUN $8.14
  • COLL $3.93
  • P/E Ratio
  • FSUN $12.63
  • COLL $14.55
  • Revenue Growth
  • FSUN 1.38
  • COLL 11.41
  • 52 Week Low
  • FSUN $31.70
  • COLL $23.23
  • 52 Week High
  • FSUN $45.32
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • FSUN 39.12
  • COLL 43.16
  • Support Level
  • FSUN $32.05
  • COLL $23.23
  • Resistance Level
  • FSUN $34.70
  • COLL $27.57
  • Average True Range (ATR)
  • FSUN 1.78
  • COLL 1.45
  • MACD
  • FSUN 0.02
  • COLL -0.08
  • Stochastic Oscillator
  • FSUN 35.97
  • COLL 51.82

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: